UACT Statements on the decision by the Chile Ministry of Health to support a compulsory license on HCV drug patents
2018-03-10
On March 9, 2018, the Chile Ministry of Health issued two documents outlining its decision to recommend a compulsory license on hepatitis C virus (HCV) drug patents. The hepatitis C virus can lead to cancer of the liver and other serious and life threatening health issues. The new drugs to treat HCV are effective for many patients, but in many countries are so expensive that access is limited. When patent barriers are overcome, affordable generic versions of the drugs are available, and treatment access is dramatically improved. Dr. Gilberto Lopes, a member of UACT and also of the UACT Expert Advisory Board offered this statementRead More →